BACKGROUND: Genome-wide association studies identified the FTO (fat mass and obesity gene) gene as an important determinant of body weight. More recently, the FTO gene was reported to be associated with other outcomes, including major risk factors for chronic kidney disease (CKD). We investigated the role of this gene in the risk of end-stage renal disease (ESRD) caused by CKD. METHODS: We conducted two large population-based case-control studies of ESRD. Study 1 compared 984 haemodialysed patients with ESRD with 2501 participants in the Czech post-MONICA study; Study 2 compared 1188 patients included in a kidney transplantation programme for ESRD with 6681 participants in the Czech HAPIEE study. The frequencies of the FTO rs17817449 single nucleotide polymorphism genotype were compared between cases and controls. RESULTS: The FTO rs17817449 genotype was significantly associated with CKD in both studies (P-values 0.00004 and 0.006, respectively). In the pooled data, the odds ratios of CKD for GG and GT, versus TT genotype, were 1.37 (95% confidence interval 1.20-1.56) and 1.17 (1.05-1.31), respectively (P for trend <0.0001). Among haemodialysed and kidney transplant patients, the onset of ESRD in GG homozygotes was 3.3 (P = 0.012) and 2.5 (P = 0.032) years, respectively, earlier than in TT homozygotes. CONCLUSIONS: These two large independent case-control studies in the general population found robust associations between the FTO rs17817449 polymorphism and the ESRD. The results suggest that the morbidities associated with the FTO gene include CKD.

Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–894. PubMed PMC

Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39:724–726. (Corrigendum in Nat Genet 2007; 39: 1285) PubMed

Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3:e115. PubMed PMC

Chang YC, Liu PH, Lee WJ, et al. Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. Diabetes. 2008;57:2245–2252. PubMed PMC

Gerken T, Girard CA, Tung YC, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318:1469–1472. PubMed PMC

Sanchez-Pulido L, Andrade-Navarro MA. The FTO (fat mas and obesity associated) gene codes for a novel member of the non-heme dioxygenase superfamily. BMC Biochem. 2007;8:23. PubMed PMC

Fawcett KA, Barroso I. The genetics of obesity: FTO leads the way. Trend Genetics. 2010;26:266–274. PubMed PMC

Zimmermann E, Kring SI, Berentzen TL, et al. Fatness-associated FTO gene variant increases mortality independent of fatness-in cohorts of Danish men. PLoS One. 2009;4:e4428. PubMed PMC

Brennan P, McKay J, Moore L, et al. Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol. 2009;38:971–975. PubMed PMC

Lyssenko V, Jonsson A, Alqren P, et al. Clinical risk factors, DNA variants and the development of type 2 diabetes. N Engl J Med. 2008;359:2220–2232. PubMed

Pausova Z, Syme C, Abrahamowicz M, et al. A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French Canadians. Circ Cardiovasc Genet. 2009;2:260–269. PubMed

Barber TM, Bennett AJ, Groves CJ, et al. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia. 2008;51:1153–1158. PubMed

Hubacek JA, Staněk V, Gebauerová M, et al. A FTO variant and risk of acute coronary syndrome. Clin Chim Acta. 2010;411:1069–1072. PubMed

Freathy RM, Timpson NJ, Lawlor DA, et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 2008;57:1419–1426. PubMed PMC

Keller L, Xu W, Wang HX, et al. The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study. J Alzheimers Dis. 2011;23:461–469. PubMed

Ho AJ, Stein JL, Hua X, et al. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A. 2010;107:8404–8409. PubMed PMC

El Nahas M, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365:331–340. PubMed

Levey AS, Astor BC, Stevens LA, et al. Chronic kidney disease, diabetes, and hypertension: what’s in a name. Kidney Int. 2010;78:19–22. PubMed

El Nahas M. Cardio-kidney-damage: a unifying concept. Kidney Int. 2010;78:14–18. PubMed

Satko SG, Sedor JR, Iyengar SK, et al. Familial clustering of chronic kidney disease. Semin Dial. 2007;20:229–236. PubMed

Luttropp K, Lindholm B, Carrero JJ, et al. Genetics/Genomics in chronic kidney disease–towards personalized medicine? Semin Dial. 2009;22:417–422. PubMed

Cífková R, Skodová Z, Bruthans J, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis. 2010;211:676–681. PubMed

Tunstall-Pedoe H, editor. MONICA Monograph and Multimedia Sourcebook. Geneva: World Health Organisation; 2003.

Peasey A, Bobak M, Kubinova R, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health. 2006;6:255. PubMed PMC

Hubacek JA, Bohuslavova R, Kuthanova L, et al. The FTO gene and obesity in a large Eastern European population sample: the HAPIEE study. Obesity. 2008;16:2764–2766. PubMed

Hubacek JA, Pitha J, Adamkova V, et al. A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies. Clin Chem Lab Med. 2009;7:387–390. PubMed

Nordfors L, Lindholm B, Stenvinkel P. End-stage renal disease: not an equal opportunity disease: the role of genetic polymorphisms. J Intern Med. 2005;258:1–12. PubMed

Salanti G, Amountza G, Ntzani EE, et al. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005;13:840–848. PubMed

Cho YM, Kim TH, Lim S, et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia. 2009;52:253–261. PubMed

Kang ES, Kim MS, Kim CH, et al. Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea. Transplantation. 2009;88:693–698. PubMed

Gu HF, Alvarsson A, Brismar K. The common FTO genetic polymorphism rs9939609 is associated with increased BMI in type 1 diabetes but not with diabetic nephropathy. Biomark Insights. 2010;5:29–32. PubMed PMC

Yi C, Yang CG, He C. A non-heme iron-mediated chemical demethylation in DNA and RNA. Acc Chem Res. 2009;42:519–529. PubMed PMC

Calvanese V, Lara E, Kahn A, et al. The role of epigenetics in aging and age-related diseases. Ageing Res Rev. 2009;8:268–276. PubMed

Gluckman PD, Hanson MA. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int J Obes (Lond) 2008;32(Suppl):S62–S71. PubMed

Gemma C, Sookoian S, Alvariñas J, et al. Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity (Silver Spring) 2009;17:1032–1039. PubMed

Association between FTO polymorphism and COVID-19 mortality among older adults: A population-based cohort study

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?